Clinical Immunoassays Market By Product (Immunoanalyzers, Reagents, and Kits) By Application (Cancer Testing/ Diagnostics, Cardiovascular Diagnostics, Others) By End-Users (Hospitals, Laboratories, Others) Regional Analysis & Forecast to 2026

  • OI-88
  • |
  • Published date: Mar, 2019
  • |
  • In Vitro Diagnostics
  • |
  • Pages

An immunoassay is an analytical method used to detect health problems or conditions based on the reaction of an antigen or antibody. Immunoassays rely on an analysis of the immunological properties of the analytes. Immunoassay techniques, which are sensitive and specific tests, are used in disease diagnosis, therapeutic drug monitoring and pharmacokinetic and bioequivalence studies in the fields of drug discovery and the pharmaceutical industry.

Immunoassays rely on various technological platforms for catering to different clinical settings. Current technology platforms include enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay (CLIA), fluorescence immunoassay (FIA) and radio immunoassay (RIA). Most of these platforms cater to large laboratory and hospital settings. Rapid diagnostic technologies, like lateral flow method, are used in point-of-care settings that need minimal infrastructure and are mostly user-friendly. Additionally, there are new emerging technologies for immunoassay like the multiplex immunoassay and the PCR-based immunoassay.

Market Overview

Global Clinical Immunoassays Market was valued at .... million in 2018 and is estimated to reach $... million by 2026, registering a CAGR of ….% from 2018 to 2026. The global Clinical Immunoassays market is segmented based on the product type, application, end user, and geography and the market share of applications such as infectious diseases, oncology, and endocrinology is expected to increase to XX%, XX%, and XX% in 2018 from XX%, XX%, and XX% in 2013, respectively. This is attributed to the increasing prevalence of diseases in these segments along with the continuous product innovations and launches.

By application, the immunoassays market is classified into infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications


By Product Type: Immunoanalyzers, Reagents, and Kits.

By-product and service, the market is segmented into reagents and immuno analyzers, kits, and software. The immunoassay reagents and kits segment accounted for the largest share of this market in 2018.

By Application: Cancer testing/ diagnostics, Cardiovascular Diagnostics, Infectious disease diagnostics, Bone and Mineral diagnostics, Endocrinology, Diabetes Testing, Autoimmune disease diagnostics, Drug of Abuse Testing and Others.

In 2017, the infectious diseases segment accounted for the largest share of the immunoassays market. The large share of this segment can be accounted to the infectious diseases due to the increasing incidence of infectious diseases and the rising number of product approvals in this segment

By End-users: Hospitals, Laboratories, Academics, Others

The immunoassays market is segmented into clinical laboratories, hospitals, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies and other end users. The hospital's segment attributed to the largest share of the immunoassays market in 2018

By Geography:  North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

The Asia Pacific is anticipated to register the highest rate of growth over the forecast time period. According to the WHO (World Health Organization), about half of children’s deaths were caused by infections. The WHO also estimated that about 1 million new cases of tuberculosis are registered in China. North America dominates the market due to the technological advancement in immunoassay products and rising incidence of chronic diseases like cardiovascular and thyroid diseases.

The report covers in-depth analysis on Clinical Immunoassays Market. The report assesses the Clinical Immunoassays pipeline by stage of development (early development, pre-clinical, clinical and in approval), by application (oncology, cardiology, endocrinology, infectious diseases, and others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.

The report includes in-depth company profiles of key players in Clinical Immunoassays Market. The company profile includes key information on overview, financial highlights, product portfolio, business strategies, and key recent developments.

The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.


  • Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Clinical Immunoassays Market

  • Provides a comparative analysis of key marketed products and pipeline Clinical Immunoassays market products

  • Provides key information on players involved on the Clinical Immunoassays Market

  • Provides a complete overview of market segments and the regional outlook of Clinical Immunoassays Market

  • Provides in-depth coverage of key news related to Clinical Immunoassays Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. Market estimation and forecasting involve the following steps:

  • Data Collation (Primary & Secondary)

  • In-house Estimation (Based on proprietary databases and Models)

  • Market Triangulation

  • Forecasting

  • Market-related information is assembled from both primary and secondary sources.

  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.

  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. 


Choose Licence Type

Credit card Logo
Inquiry Before Buying

Related Reports

Contact Us

Email Us at: | Reach Us at: +91 966 6620 365 | +1 857 444 9369 (US)  tick-under  tick-under